Which cancers are associated with an elevated hematocrit?

Cancers Associated with Elevated Hematocrit

The primary cancer that causes elevated hematocrit is renal cell carcinoma (kidney cancer), which produces erythropoietin leading to secondary polycythemia, while polycythemia vera represents a myeloproliferative neoplasm that directly causes elevated hematocrit through clonal proliferation of red blood cells.

Primary Hematologic Malignancy

Polycythemia Vera (PV) is the most important cancer to consider with elevated hematocrit:

• PV is a myeloproliferative disorder characterized by clonal proliferation of red blood cells
• Approximately 95% of PV patients carry the JAK2V617F mutation 1
• Diagnosis should be suspected when hemoglobin/hematocrit exceeds the 95th percentile adjusted for sex and race 2
• Key diagnostic feature: Serum erythropoietin (EPO) levels are LOW in PV, distinguishing it from secondary causes 2
• PV patients typically present with hematocrit >60% in men or >55% in women, though lower values can occur with concurrent iron deficiency or bleeding 2

Solid Tumors Causing Secondary Erythrocytosis

Renal Cell Carcinoma is the most common solid tumor associated with elevated hematocrit:

• Kidney tumors produce erythropoietin, causing paraneoplastic erythrocytosis
• Prospective data shows increased kidney cancer risk with higher baseline hematocrit levels (relative risk 4.94 for hematocrit ≥47% vs ≤43%) 3
• This represents a true paraneoplastic syndrome where the tumor inappropriately secretes EPO

Other solid tumors that can rarely cause elevated hematocrit through inappropriate EPO production include:

• Hepatocellular carcinoma
• Cerebellar hemangioblastoma
• Uterine leiomyomas (fibroids)
• Pheochromocytoma

Critical Diagnostic Algorithm

When encountering elevated hematocrit:

1. Measure serum EPO level first 2:

   • Low EPO → Strongly suggests polycythemia vera (proceed to JAK2 mutation testing and bone marrow biopsy)
   • High EPO → Indicates secondary erythrocytosis (evaluate for renal tumors, other EPO-producing tumors, or hypoxic conditions)
   • Normal EPO → PV remains possible; proceed with further workup

2. Exclude secondary causes 1:

   • Imaging of kidneys to rule out renal cell carcinoma
   • Assess for hypoxia (arterial oxygen saturation, pulmonary disease)
   • Rule out high oxygen affinity hemoglobin variants

3. Confirm PV if suspected:

   • JAK2V617F mutation testing (positive in 95% of cases) 1
   • Bone marrow biopsy showing panmyelosis with erythroid and megakaryocytic proliferation 2

Important Clinical Pitfalls

• Do not assume all elevated hematocrit is benign dehydration - persistent elevation requires workup for malignancy
• Iron deficiency can mask PV - a PV patient with concurrent iron deficiency may have a falsely normal hematocrit that rises after iron repletion 2
• Lung cancer does NOT typically cause elevated hematocrit - the association seen in epidemiologic studies 3 likely reflects smoking-related hypoxia rather than tumor-mediated erythrocytosis
• Most other solid tumors (breast, colorectal, lung) are associated with ANEMIA, not elevated hematocrit 4, 5